Phase IIA Clinical Trial to Test the Efficacy and Safety of Toremifene in Men with High-Grade Prostatic Intraepithelial Neoplasia
Clinical Prostate Cancer · 2003-06 · 2 (1) · 24-31
DOI: 10.3816/cgc.2003.n.009 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Clinical Prostate Cancer, 2003-06. Verfasst von Mitchell S Steiner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Tennessee, Memphis, 38104, USA. msteiner@utmem.edu. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, University of Tennessee, Memphis, 38104, USA. msteiner@utmem.edu
Zitieren
APA
Steiner, M. S., & Pound, C. R. (2003). Phase IIA Clinical Trial to Test the Efficacy and Safety of Toremifene in Men with High-Grade Prostatic Intraepithelial Neoplasia. Clinical Prostate Cancer, 2(1), 24-31. https://doi.org/10.3816/cgc.2003.n.009
Vancouver
Steiner MS, Pound CR. Phase IIA Clinical Trial to Test the Efficacy and Safety of Toremifene in Men with High-Grade Prostatic Intraepithelial Neoplasia. Clinical Prostate Cancer. 2003;2(1):24-31. doi:10.3816/cgc.2003.n.009
BibTeX
@article{Steiner2003,
author = {Steiner, Mitchell S and Pound, Charlie R},
title = {Phase IIA Clinical Trial to Test the Efficacy and Safety of Toremifene in Men with High-Grade Prostatic Intraepithelial Neoplasia},
journal = {Clinical Prostate Cancer},
year = {2003},
volume = {2},
number = {1},
pages = {24--31},
doi = {10.3816/cgc.2003.n.009}
}
EUVIMED